Daxor Corporation (DXR) vs Nephros Inc. (NEPH)
Daxor Corporation and Nephros Inc. are both Medical Instruments & Supplies companies. Daxor Corporation is the larger, with a market value of $66.5M against $45.0M — 1.5× the size. Daxor Corporation trades at the lower P/E: 5.1× against 27.2×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against −52.1%. Nephros Inc. has the higher net margin (8.38% vs −251.9%) and the higher return on invested capital (14.1% vs 0.00%). Across the 17 metrics below, Nephros Inc. leads on 10 and Daxor Corporation on 7.
Valuation
Profitability
| Metric | DXR | NEPH | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 0.00% | 61.26% | 54.62% |
| Operating margin | 0.00% | 7.92% | 1.64% |
| Net margin | (251.91%) | 8.38% | 0.00% |
| Free cash flow margin | 224.51% | (3.19%) | 1.61% |
| Return on equity | 37.62% | 16.10% | 0.00% |
| Return on assets | 35.90% | 12.39% | 0.00% |
| Return on invested capital | 0.00% | 14.11% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack